Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
David Mathiesen MD

David S. Mathiesen MD

PhD Fellow, Center for Clinical Metabolic Research, Copenhagen University Hospital – Herlev and Gentofte, Hellerup, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

David Siersbæk Mathiesen is a medical doctor and a PhD fellow at the Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Denmark. Since 2018, he has been involved in research within the field of endocrinology and metabolism, working primarily with type 1 diabetes but also with a broad range of other topics, such as gut-derived hormones, amylin, neuronostatin and genetics. Currently, he is conducting a phase 2b trial investigating the effect of low-dose colchicine for the reduction of cardiovascular risk in type 1 diabetes. Furthermore, he has experience as sub-investigator in large-scale clinical trials and is currently supervising projects exploring the effects of amylin on bone metabolism in type 1 diabetes, the effects of GLP-1/GLP-2/GIP on bone metabolism in type 2 diabetes and in total pancreatectomy as well as the effects of GIP on glucose metabolism. In addition, he has served as chairman of an international conference (EASD). As a clinician, David has extensive teaching experience in the fields of internal medicine, emergency medicine, general practice, and neurology.


Dr. Mathiesen has no relevant disclosures.